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capacity (31 ± 14% vs. 40 ± 14%, p = 0.02).We found a statistically
no signiﬁcant difference for the other functional features or HDL
properties between the groups. Conclusions: Small HDL particles,
low HDL phospholipid content and decreased cholesterol efﬂux
capacity were related to magnitude of subclinical atherosclerosis and
hypoalphalipoproteinemia in a primary care population.
doi:10.1016/j.bbacli.2015.05.039
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Peri/epicellular protein disulﬁde isomerase reshapes vascular
architecture to counteracts constrictive remodeling
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Whole-vessel remodeling critically determines lumen caliber in
vascular (patho)physiology and is reportedly redox-dependent. We
hypothesized that cell-surface pool of the endoplasmic reticulum
(ER) redox chaperone Protein Disulﬁde Isomerase-A1 (peri/epi-
cellular = pecPDI), known to support thrombosis, also regulates
disease-associated vascular architecture. In human coronary athero-
mas, PDI expression inversely correlated with constrictive remodel-
ing and plaque stability. In rabbit iliac artery overdistension model,
there was unusually high PDI upregulation (~25-fold vs. basal
14 days post-injury), involving both intracellular and pecPDI.
Silencing PDI by siRNA in vitro induced ER stress markers
upregulation and apoptosis (assessed by TUNEL assay). PDI knock-
down also upregulated proliferation marker PCNA and decreased
differentiation marker calponin-C. In contrast, pecPDI neutralization
with anti-PDI antibodies (PDIAb) did not enhance ER stress or
apoptosis. In vivo pecPDI neutralization with PDIAb-containing
perivascular gel from days 12–14 post-injury promoted ca. 25%
decrease in maximally dilated arteriographic vascular caliber and
corresponding whole-vessel circumference loss at optical coherence
tomography, without changing neointima, suggesting constrictive
remodeling. This was accompanied by decreased oxidant generation
and nitrogen oxide production. Constrictive remodeling was corrob-
orated by marked changes in collagen organization, switching from
circumferential to radial ﬁber orientation and to more rigid ﬁber
type. Cytoskeleton architecture was also disrupted, with loss of stress
ﬁber coherent organization and switch from thin to medium-
thickness actin ﬁbers, all leading to impaired viscoelastic ductility.
Total and PDI-associated expressions of beta1-integrin, as well as
cell-surface reduced beta1-integrin levels, were diminished after
PDIAb treatment, implicating beta1-integrin as a likely pecPDI target
during vessel repair. Integrin signaling is a master regulator of
mechanobiology connecting the extracellular matrix environment to
focal adhesion and actin-cytoskeleton. Indeed, FAK phosphorylation,
a downstream beta1-integrin effector, was decreased by PDIAb. Thus,
PDI is highly upregulated after injury and reshapes matrix and
cytoskeleton architecture to support an anticonstrictive remodeling
effect. Such ﬁndings suggest an important role for PDI in lumen




Biochemical and histopathological parameters analyzed
in rabbits fed a diet enriched with fat/sucrose/cholesterol
and treated with vitamin D
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Introduction: Low levels of Vitamin D increase risk of cardiovas-
cular diseases. This study aims to assess the effects of vitamin D in an
experimental model of rabbits fed a diet enriched with fat/sucrose/
cholesterol (FSC). Methods: The rabbits were fed a chow enriched
with fat 10%/sucrose 40%/cholesterol 0.5% for three months and
thereafter, the chow were substituted for FSC with cholesterol 0.1%
or standard chow for more 3 months. The following groups were
formed: I — FSC 0.5/0.1%; GII — FSC 0.5/0.1% + Vit D 1000 IU/day;
GIII — FSC 0.5%/ standard chow (SC) and GIV — FSC 0.5%/ standard
chow+ 1000 IU of Vit D/day. In periods of 0, 3 and 6 months the
following parameters were evaluated: weight, lipid proﬁle and
serum glucose. After 6 months the animals were euthanized and
the aortas were removed for atheroma plaques analysis. Statistical
analysis was performed by Kruskal–Wallis non-parametric tests
followed by Dunn's test. Results: After 6 months, the following
values were observed, respectively, in groups I, II, III and IV: total
cholesterol (mg/dL):420 ± 128; 363 ± 119; 149 ± 136; 162 ± 132.
Triglycerides(mg/dL): 172 ± 58; 202 ± 79; 74 ± 24; 63 ± 13. Glu-
cose (mg/dL):97 ± 5; 92 ± 13; 100 ± 18; 106 ± 11. Plaques in
aorta(%): 83 ± 24,62; 84,64 ± 23,22; 15,38 ± 5,95; 24,11 ± 8,81.
Intima/media ratio in arch aorta: 2.98 ± 2.16; 2.57 ± 1.06; 2.74 ±
1.22; 1.35 ± 0.39*. Thoracic aorta: 2.13 ± 1.15; 1.80 ± 1.05; 1.54 ±
0.52; 1.48 ± 0.42. Abdominal aorta: 1.73 ± 0.55; 2.06 ± 1.23; 1.59 ±
0.41; 1.15 ± 0.47. The histopathological aspects of aortas in groups
III and IV were more ﬁbrous than in groups I and II, independently of
vitamin D treatment, however, lower intima/media rate was
observed in the group IV that had received the standard diet and
vitamin D. Conclusion: The normalization of the diet improved the
lipid proﬁle and atherosclerotic plaques in aorta, with beneﬁcial
effect of vitamin D.
doi:10.1016/j.bbacli.2015.05.041
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Introduction: The statin class of drugs is the ﬁrst choice in
dyslipidemic patients, to reduction of plasma cholesterol levels,
especially LDL (low density lipoprotein) for the prevention of
cardiovascular disease (CVD). However, fatigue is a side effect in
some patients, possibly by inhibiting melovanato conversion to
coenzyme Q10 (CoQ10), a cofactor in the electron transport chain for
the energy formation, in the same cascade of cholesterol formation.
CoQ10 supplementation helps reduce the effects caused by contin-
uous use of statins. In traditional Chinese Medicine, the Withania
somnifera (or Ashwagandha), is considered an adaptogen herbal and
indicated for fatigue and hipocholesterolemic use. Methods: In this
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study of case, a young patient with dyslipidemia in statin use only,
with reports of chronic fatigue, was selected to receive supplemen-
tation of CoQ10 (100 mg) and Withania somnifera (300 mg dry
extract), in capsules, blindly for 30 days each, in addition to
answering validated questionnaire on fatigue (Piper Fatigue Scale-
Revised [PFSR]), usual dietary recall and perform biochemical tests
after each period. Results: Both supplementation shows improved
their symptoms of fatigue reported (PFSR basal 69,1% versus CoQ10
50,0% and Withania somnifera 43,2%), but there was a change of
biochemical parameters for total cholesterol (185 mg/dL to 313 mg/dL),
high density lipoprotein (HDL) (43 mg/dL to 55 mg/dL), LDL (124 mg/dL
to 226 mg/dL) and triglycerides (91 to 159 mg/dL) after use ofWithania
somnifera, in comparison with CoQ10, without alter in your habitual
dietary. Conclusion: Therefore, the use of herbal medicine can be a viable
alternative and effective supplementation in patients reporting fatigue,
but further studies are needed for the population in continuous use of




Isolated hypercholesterolemia and consumer of cardioprotective
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Introduction: Diet is one of the changes in lifestyle recommended
for dyslipidemic patients, such as prevention of cardiovascular
events. Nutrition aims to stimulate the consumption of cardi-
oprotective food, the functional bioactive compounds: ﬁber, omega
3–6–9 and polyphenols. Objective: Reduction of plasma levels of
total cholesterol and fractions, in a hyperlipidemic patient without
medication. Methodology: hyperlipidemic patient received an orien-
tation cardioprotective foods (olive oil, yogurt, green tea, ﬂaxseed,
dark chocolate, ﬁsh, oats, soybeans and by-products, grape juice, nut,
avocado), with the recommendation for daily consumption to reduce
hypercholesterolemia, as the IV Guideline on Dyslipidemia. The
inclusion in the food routine was free choice. A food frequency
questionnaire of these foods and biochemical tests were obtained
before and after a follow-up three months. We selected a woman of
44 years without use of medications in primary prevention. Results:
Over the frequency of cardioprotective foods, the patient reported
using in the initial evaluation, only olive oil and ﬁsh, in the
recommendations. During treatment, the patient included, besides
the two already earlier: yogurt, linseed, dark chocolate, oats, whole
grape juice and oilseeds. Other foods (green tea, soybeans and by-
products and avocado) were included, but at a lower frequency than
the one suggested. The plasma levels decreased, in basal versus
90 days, 31.41% LDL-cholesterol, 8.19% HDL-cholesterol and 11.00%
triglyceride. The anthropometric measurements were reduced too:
weight (61.1 to 59.0 kg), body mass index (23.59 to 22.77 kg/m2)
and waist circumference (84.5 to 82.5 cm). Conclusion: A frequent
use of cardioprotective foods, can reduce the plasma levels of LDL-
cholesterol, with low interference in HDL-cholesterol.
doi:10.1016/j.bbacli.2015.05.043
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Cyclo-oxygenase gene expression in acute myocardial infarction:
A case report
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Introduction: The cyclo oxygenase (COX) enzymes are directly
involved in inﬂammation. Arachidonic acid is converted by COX to
prostaglandins (PG). PG participates in platelet activation, vasocon-
striction, gastrointestinal protection and bronchodilation. These
processes show an important association of COX-2 levels with major
adverse cardiovascular events. This effect suggests protection of
COX-2 in individuals who do not have it inhibited artiﬁcially. The
objective of this report is to demonstrate the association between
high COX-2 expression during the course of a patient with acute
myocardial infarction (AMI) undergoing coronarography. Case
report: A 54 year-old female patient, African descent, hypertensive
and former user of cocaine was admitted through the emergency
room with chest pain and anterior wall ischemia in the EKG. About
45 days before admission, she had been treated with angioplasty
with conventional stenting in the anterior descending artery. Serial
blood samples of each 6 h were made to assess the gene expression
of COX-2 and NF-kB activity. Our results showed a rise of COX-2 gene
expression and NF-kB after AMI diagnosis and coronarography
during time. Conclusion: Atherosclerosis is the major cause behind
major adverse cardiovascular events. The COX-2 has increased its
expression in symptomatic atherosclerotic plaques however plate
regions have fat cells that have no expression, suggesting that the
mechanism behind its regulation is more complex. Areas with higher
expression of COX-2 with great macrophage activity are subject to
instability and rupture, triggering the cascade of events culminating
in necrosis. In contrast, blocking the COX-2 action aggravates
ischemia because of its vasoconstrictor effect with consequent
increase in myocardial oxygen consumption. The balance between
the intensity of the inﬂammatory reaction and plaque instability
seems to be the scales between the concentration of PG E2 which is
pro instability of the plaque, and PG I2 a natural pro angiogenesis
stimulator
doi:10.1016/j.bbacli.2015.05.044
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